Article
Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
British journal of cancer - 9 Sept 2002
Martínez C, García-Martín E, Pizarro R M, García-Gamito F J, Agúndez J A G
Abstract excerpt
Cytochrome P450 3A is a drug-metabolising enzyme activity due to CYP3A4 and CYP3A5 gene products, that is involved in the inactivation of anticancer drugs. This study analyses the potential of cytochrome P450 3A enzyme in human colorectal cancer to impact anticancer therapy with drugs that are cytochrome P450 3A substrates. Enzyme activity, variability and properties, and the ability to inactivate paclitaxel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
